Dysbiosis and development of pre-eclampsia and eclampsia

Main Article Content

Carolina Soares Cardoso
Roberta Furtado Stivanin Rachid Novais

Abstract

Objective: Analyze the relationship between dysbiosis of the intestinal, vaginal and oral microbiomes with the development of preeclampsia and eclampsia. Methods: This integrative review involved searching studies in the National Library of Medicine, Latin America and the Caribbean Literature on Health and Cochrane Library databases, where fifteen articles on the topic were found, after selecting the inclusion and exclusion criteria. Results: All articles analyzed are of the clinical trial type. Among them, thirteen assess the intestinal microbiome, one assesses the vaginal microbiome and one simultaneously assesses the intestinal, vaginal and oral microbiomes. Final considerations: There are bacteria with protective action and others with deleterious action involved in the mechanism of pre-eclampsia pathophysiology. The intestinal barrier created by protective bacteria that produce short-chain fatty acids has anti-inflammatory and antioxidant effects that can prevent placental inflammation and consequently the development of PE, and it is through the investigation of the metabolites produced by these bacteria that it will be possible to focus targets for prevention and treatment of the disease.

Article Details

How to Cite
CardosoC. S., & NovaisR. F. S. R. (2024). Dysbiosis and development of pre-eclampsia and eclampsia. Revista Eletrônica Acervo Médico, 24, e16604. https://doi.org/10.25248/reamed.e16604.2024
Section
Revisão Bibliográfica

References

1. BRASIL. Ministério da Saúde. Secretaria de Atenção Primária à Saúde. Departamento de Ações Programáticas. Manual de gestação de alto risco [recurso eletrônico] / Ministério da Saúde, Secretaria de Atenção Primária à Saúde. Departamento de Ações Programáticas – Brasília: Ministério da Saúde, 2022; 692.

2. BENÍTEZ-GUERRERO T, et al. Gut Microbiota Associated with Gestational Health Conditions in a Sample of Mexican Women. Nutrients, 2022; 14: 4818.

3. CHEN X, et al. Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation. Gut, 2020; 69: 513–522.

4. CHANG Y, et al. Short-chain fatty acids accompanying changes in the gut microbiome contribute to the development of hypertension in patients with preeclampsia. Clin Sci (Lond), 2020; 134(2): 289–302.

5. GELDENHUYS J, et al. Diversity of the gut, vaginal and oral microbiome among pregnant women in South Africa with and without pre-eclampsia. Front. Glob. Womens Health, 2022; 3: 810673.

6. GINJA FO. Microbioma e desfechos obstétricos adversos. Tese de Mestrado (Mestrado Integrado em Medicina - Área Científica de Fisiopatologia) - Faculdade de Medicina da Universidade de Coimbra, Portugal, 2021; 36.

7. HUANG L, et al. Gut microbiota changes in preeclampsia, abnormal placental growth and healthy pregnant women. BMC Microbiol, 2021; 21: 265.

8. LEVY M, et al. Dysbiosis and the immune system. Nature Reviews Immunology, 2017; 17(4): 219-232.

9. LV L-J, et al. Early-Onset Preeclampsia Is Associated With Gut Microbial Alterations in Antepartum and Postpartum Women. Front. Cell. Infect. Microbiol. 2019; 9: 224.

10. LV L-J, et al. Deep metagenomic characterization of gut microbial community and function in preeclampsia. Front. Cell. Infect. Microbiol. 2022; 12: 933523.

11. LI P, et al. Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study. BMC Med. 2022; 20: 443.

12. LIN CY, et al. Severe preeclampsia is associated with a higher relative abundance of Prevotella bivia in the vaginal microbiota. Sci Rep, 2020; 10: 18249.

13. MIAO T, et al. Decrease in abundance of bacteria of the genus Bifidobacterium in gut microbiota may be related to pre-eclampsia progression in women from East China. Food & Nutrition Research, 2021; 65.

14. MEIJER S, et al. Gut Micro- and Mycobiota in Preeclampsia: BacterialComposition Differences Suggest Role in Pathophysiology. Biomolecules, 2023; 13: 346.

15. PEIXOTO-FILHO FM, et al. Predição e prevenção da pré-eclâmpsia. Femina, 2023; 51(1): 6-13.

16. SILBERGELD EK. The microbiome: Modulator of pharmacological and toxicological exposures and responses. Toxicologic pathology, 2017; 45(1): 190-194.

17. WITKIN SS. The vaginal microbiome, vaginal anti-microbial defence mechanisms and the clinical challenge of reducing infection-related preterm birth. BJOG, 2015; 122: 213–219.

18. WANG J, et al. Gut Microbiota Dysbiosis and Increased Plasma LPS and TMAO Levels in Patients With Preeclampsia. Front. Cell. Infect. Microbiol. 2019; 9: 409.

19. WANG J, et al. Gut microbiota dysbiosis in preeclampsia patients in the second and third trimesters. Chinese medical jornal, 2020; 133(9): 1057–1065.

20. WU X, et al. Gut microbiota and hypertensive disorders in pregnancy: evidence from the Mendelian randomization study. Aging, 2023; 15(17): 9105–9127.

21. XIONG Z, et al. The causal role of intestinal microbiome in development of pre-eclampsia. Funct Integr Genomics, 2023; 23: 127.